Find Academic Supervisors

• Urology
• Male Infertility
• Sexual Medicine
• +5 more

Katherine Rotker, MD is an Assistant Professor in the Department of Urology at Yale School of Medicine. She specializes in male infertility, sexual medicine, and general urology, with clinical practice locations at Lawrence + Memorial Hospital (New London, CT) and the Yale Fertility Center (Orange, CT). Her academic roles include advanced fellowship training in male infertility/andrology from Brown University/Rhode Island Hospital (2017) following residency and internship at the same institution. Dr. Rotker completed her MD at University of Massachusetts Medical School (2011) and earned a BA in Biology from Dartmouth College (2006). Research focuses include gender equity within urology, fertility topics like sperm DNA fragmentation, and reproductive health trends. She actively publishes on vasectomy protocols, telemedicine applications, and clinical practice policies. Notable work includes studies on post-vasectomy semen analysis optimization and ICU provider knowledge of posthumous sperm retrieval. Awards include recognition in the 2024 and 2025 'Top Doctors' lists. Her clinical expertise spans microsurgeries (varicocele repair, vasectomy reversal), erectile dysfunction management, and Peyronie's disease treatment. Dr. Rotker emphasizes patient comfort in sensitive consultations, leveraging her gender perspective to improve male health accessibility. She collaborates with reproductive endocrinologists to support couples through fertility challenges, advocating for destigmatizing discussions around common urologic conditions.

• Reproductive Biology
• Endometriosis
• Stem Cell Biology
• +5 more

Aya Tal is an Associate Research Scientist at Yale University's Yale School of Medicine, affiliated with the Department of Obstetrics, Gynecology & Reproductive Sciences. She holds a PhD in Cellular, Molecular & Developmental Biology from the Graduate Center of the City University of New York (2011). Her research focuses on reproductive biology, endometriosis, stem cell biology, and hormonal therapies, with a particular emphasis on understanding mechanisms underlying infertility, ovarian reserve, and endometrial pathology. Her work includes studies on bone marrow cell trafficking in endometriosis, the role of mesenchymal stem cells in disease dissemination, and clinical trials evaluating estrogen therapy and IVF success rates. She collaborates with prominent researchers such as Hugh Taylor, Myles Alderman, and Diane Krause. Key findings include identifying CXCR antagonists as potential treatments for endometriosis and discovering that adult bone marrow progenitors contribute to decidual cells during pregnancy. Publications span high-impact journals like PLOS Biology, Stem Cells, and JAMA Internal Medicine, with a focus on translational research linking basic science to clinical applications in reproductive health. Her research bridges cell biology, immunology, and endocrinology to address unresolved questions in reproductive medicine.

• Pediatric Endocrinology
• Growth Disorders
• Adrenal Disorders
• +4 more

Dr. Jasmine Gujral is an Assistant Professor of Pediatrics in the Division of Pediatric Endocrinology at Yale School of Medicine and Yale New Haven Hospital. She holds roles as the Section Education Attainment Liaison and Fellowship Program Director for Pediatric Endocrinology & Diabetes. Her research focuses on growth hormone-immune interactions using omic techniques (e.g., mass spectrometry, proteomics) and clinical interests include growth disorders, adrenal disorders, and disorders of sexual development. She received her MBBS from Lokmanya Tilak Municipal Medical College (India) and completed residency at Saint Peter's University Hospital (New Jersey) and fellowship at Mount Sinai Hospital (New York). Dr. Gujral’s awards include the FLAME Award (2024) for mentorship and education, and travel awards for young investigators (2019). She leads the ECHO tele-mentoring program to support community pediatricians in managing complex endocrine cases. Her work addresses barriers to insulin access, diabetes care during pandemics, and genetic disorders like adrenoleukodystrophy. She is board-certified in Pediatrics and Pediatric Endocrinology. Education: MBBS (2011), Pediatrics Residency (2014), Pediatric Endocrinology Fellowship (2017) Key Research: Growth hormone immunology, genetic endocrine disorders, pediatric diabetes disparities Awards: FLAME Award (2024), Best Poster (2019)

Riccardo AutorinoView profile

Professor

• Urology
• Oncology
• Robotic Surgery
• +4 more

Riccardo Autorino, MD, PhD, is a Professor in the Department of Urology at Rush Medical College, Rush University. As Director of Surgical Innovation and Clinical Research, he specializes in robotic urologic surgery, oncology, and minimally invasive techniques. His research focuses on kidney and prostate cancers, surgical outcomes, and innovative technologies like single-port robotic surgery. He has published extensively on topics such as robotic partial nephrectomy, adjuvant therapies, and clinical decision-making models (e.g., nomograms for survival prediction). His work also addresses Peyronie’s disease, erectile dysfunction, and the impact of metabolic factors on urological health. Education: MD and PhD degrees (not further specified in text). Affiliations: Rush Medical College, ROSULA and ROBUUST Collaborative Groups. His research interests include: Prognostic biomarkers in renal cell carcinoma and urothelial cancers. Advancing robotic surgery techniques for kidney and prostate procedures. Optimizing postoperative outcomes through surgical innovation. Evaluating adjuvant therapies for high-risk cancers. Key Articles Trends (2025): Focus on robotic partial nephrectomy efficacy, adjuvant immunotherapy for upper tract urothelial carcinoma, and nomograms for predicting survival. Studies emphasize collaborative research, multicenter analyses, and machine learning applications for diagnostic prediction. Grants & Advising: No specific grants listed, but leads collaborative groups like ROBUUST. No students explicitly mentioned in text. Labs/Teams: Surgical Innovation Program at Rush University, focusing on single-port robotic techniques and clinical research initiatives.

• Stress Neurobiology
• Drug Development for Psychiatric Disorders
• Neuropharmacology
• +5 more

Caroline A Browne, PhD, is a Research Assistant Professor in the Department of Pharmacology & Molecular Therapeutics at the Uniformed Services University of the Health Sciences (USUHS). Her research focuses on stress neurobiology, drug development for psychiatric disorders, and opioid receptor signaling in depression. She holds a B.Sc. in Neuroscience from University College Cork (2006) and a Ph.D. in Pharmacology (2012), followed by postdoctoral training at the University of Pennsylvania (2016). Her work spans preclinical studies on antidepressant mechanisms, with a focus on ketamine, buprenorphine, and kappa opioid receptor antagonists. Key contributions include elucidating stress-induced immune changes in the hippocampus and developing dietary methods for tryptophan depletion studies. She has received awards such as the ECNP Travel Award (2008-2009) and Penn Center for Innovation Fellowship (2015). Roles: Organized the Neuropharmacology Drug Club (2016-present) and serves on the USUHS Rat Behavioral Core and Mouse Preclinical Core advisory committees. Editorial: Guest associate editor for Frontiers in Synaptic Neuroscience (2019-present) and topic editor for the same journal (2020-present). Her research integrates translational approaches to understand depression pathophysiology, with a focus on opioid dysregulation and lateral habenula circuitry. Recent work highlights ketamine’s effects in maternal deprivation models and kappa receptor antagonists for stress-related disorders.

Jennifer HillmanView profile

Professor

• Sexuality and Aging
• LGBTQ+ Issues in Aging
• Intimate Partner Violence Among Older Adults
• +4 more

Dr. Jennifer Hillman is a Professor of Psychology at Pennsylvania State University Berks and a licensed psychologist in Pennsylvania, board certified in Geropsychology (ABPP). She specializes in research areas including sexuality and aging, LGBTQ+ issues among older adults, intimate partner violence in aging populations, problem behavior in long-term care facilities, and the experiences of grandparents raising children with autism spectrum disorder. Hillman has published over two dozen peer-reviewed articles and four books, and is a recipient of the prestigious Gerontological Society of America Fellowship and the Penn State University Teaching Fellow Award. She teaches courses in clinical, health, and social psychology, emphasizing gerontology and LGBTQ+ health. Education: Professional Diploma in Clinical Psychology, Adelphi University Ph.D. in Social Psychology, Adelphi University M.A. in Social Psychology, Adelphi University B.S. in Psychology, The College of William and Mary Research Focus: Hillman’s work bridges clinical practice and policy, addressing critical gaps in understanding aging LGBTQ+ populations’ healthcare needs, violence prevention, and family dynamics. Her studies on custodial grandparents highlight systemic supports required for families impacted by autism. She emphasizes culturally competent care and policy reforms to address disparities. Awards: Fellow of the Gerontological Society of America (2021) Penn State University Teaching Fellow Award (Year unspecified) Grants & Advising: While specific grants are not detailed, her extensive publications suggest sustained research funding. Her advising focuses on interdisciplinary approaches to aging and LGBTQ+ health. She is a vocal advocate for integrating psychological and medical interventions for older adults. Labs/Teams: Collaborates within Penn State’s aging and LGBTQ+ health initiatives, though specific lab names are not mentioned. Engages with multidisciplinary teams addressing healthcare equity and family caregiving.

Marina Oktapodas FeilerView profile

Assistant Professor

• Pediatric Environmental Epidemiology
• Maternal and Pediatric Exposure to Environmental Toxins
• Immune Dysfunction
• +4 more

Marina Oktapodas Feiler, PhD, is an Assistant Professor in the Department of Epidemiology and Environmental Health at the University at Buffalo's School of Public Health and Health Professions. Her research focuses on pediatric environmental epidemiology, particularly maternal and pediatric exposure to environmental toxins like lead, PFAS, and phthalates. She investigates links between toxin exposure and immune dysfunction, respiratory disease, vaccine efficacy, and breastfeeding outcomes. Dr. Feiler has held roles including Postdoctoral Fellow at the University of Rochester and Research Assistant Professor at Temple University. Education: BS in Psychology, University at Buffalo MS in Epidemiology, University at Buffalo (2015) PhD in Epidemiology, University of Rochester (2019) Her research has been funded by grants including the NIH Eunice Kennedy Shriver NICHD for studying air pollution's impact on pediatric respiratory hospitalizations. Professional affiliations include the International Society for Environmental Epidemiology and the Society for Pediatric and Perinatal Epidemiology. Awards & Training: T32 Toxicology Training Grant Postdoctoral Fellowship (NIEHS) Evaluation of Air Pollution and Respiratory Outcomes Grant (NICHD) Her work spans infectious disease epidemiology, environmental toxin exposure tracking, and translational public health research, with a focus on vulnerable pediatric populations.

Rachel CalogeroView profile

Professor

• Social Psychology
• Body Image
• Eating Disorders
• +6 more

Dr. Rachel Calogero is a Full Professor in the Department of Psychology at Western University and Affiliate Professor in the Department of Gender, Sexuality, and Women's Studies. Her research focuses on the intersection of social identities, stigma, and embodiment, with a particular emphasis on self-objectification theory, body image, and eating disorders. She founded the Stigma, Bodies, Objectification, and Resistance (SOBR) Lab, which investigates how social environments influence psychological well-being through qualitative and quantitative methods. She holds editorial leadership roles, including Editor-in-Chief of Sex Roles , and has contributed to prestigious journals like Body Image and Journal of Experimental Social Psychology . A Fellow of key psychological associations, she advocates for weight-inclusive health approaches and challenges systemic biases through feminist frameworks. Her work bridges clinical and applied psychology, with practical applications in eating disorder treatment and public health. Recent projects examine self-compassion’s role in physical activity motivation and the validation of fat microaggressions. She supervises graduate students like Alana Graham (MSc) and Katarina Huellemann (PhD), advancing research on intersectional mental health and social justice. Dr. Calogero’s lab emphasizes community impact, collaborating with clinical settings and advocating for inclusive wellness policies. Her research consistently highlights the need for culturally responsive interventions to address stigma and promote resilience.

• Clinical Epidemiology
• Evidence Synthesis
• Patient-Reported Outcomes
• +10 more

Carla Perrotta is an Associate Professor at the School of Public Health, Physiotherapy and Sports Science, University College Dublin. She holds dual roles as a Medical Doctor specializing in Internal Medicine, General Practice, and Clinical Effectiveness. Her academic positions include co-director of the Health Data Analytics program within the Advance Centre's Micro-credentials initiative. Perrotta’s research focuses on systematic reviews, clinical decision-making, health inequalities, and pandemic preparedness, with notable contributions in bronchiolitis management, workplace pandemic adaptation, and interventions for obesity prevention. She has led over 20 systematic reviews influencing clinical guidelines and public health policy. Her teaching portfolio includes courses on Clinical Epidemiology, Evidence Synthesis, Health Economics, and Patient-Reported Outcomes. She coordinates modules like Data Analytics for Healthcare and Health Technology Assessment. Perrotta’s interdisciplinary work spans addiction recovery among the homeless, maternal health in Argentina, and mental health stigma reduction. She collaborates internationally, including roles as a Cochrane Author and Visiting Professor at the University of Rennes 1. Her research emphasizes patient-centered approaches, leveraging diverse methodologies to amplify marginalized voices in healthcare decision-making.

• Hematology
• Bleeding Disorders
• von Willebrand Disease
• +7 more

Frank Leebeek is a Full Professor in the Department of Hematology at Erasmus MC, a leading academic medical center in the Netherlands. His research is centered on bleeding disorders, particularly hemophilia and von Willebrand disease, with a strong focus on molecular mechanisms, clinical phenotypes, and novel therapies. His research interests include the pathophysiology of von Willebrand factor, pharmacokinetics of clotting factors, platelet dysfunction, and genetic determinants of bleeding severity. He investigates both inherited and acquired coagulation disorders, aiming to improve diagnosis, treatment, and quality of life for patients. The recent articles highlight a strong trend toward translational research, combining basic science (e.g., gene editing, siRNA) with clinical studies (e.g., patient cohorts, bleeding phenotypes). His work bridges molecular hematology and clinical practice, contributing to both diagnostic innovation and therapeutic development. Frank Leebeek has supervised 29 academic works, indicating a significant role in mentoring the next generation of researchers. He collaborates widely through consortia such as the SYMPHONY consortium, TiN study group, and Willebrand in the Netherlands (WiN) study group, reflecting a networked and team-based research approach. Although no specific grants are listed, his extensive publication output suggests sustained funding and research activity. He is involved in multiple collaborative research teams focused on thrombosis and hemostasis, including national and international consortia. These teams work on standardizing care, understanding disease variability, and developing targeted therapies, particularly for rare bleeding disorders.

• Osteoarthritis
• Knee Osteoarthritis
• Disease Modeling
• +7 more

Boris Schouten is a Lecturer at Erasmus MC, Erasmus University Rotterdam, affiliated with the Department of General Practice within the Faculty of Medicine. His work bridges clinical research and primary care, with a strong focus on chronic and degenerative conditions. His research interests include osteoarthritis , men's health , cardiovascular disease , and lower urinary tract symptoms . He has contributed to key longitudinal studies such as the Krimpen study and the CHECK cohort, investigating disease progression and early diagnosis in primary care settings. The recent publications highlight a consistent trend in prospective cohort studies , disease modeling , and clinical epidemiology , particularly in aging populations and degenerative joint disorders. His work often integrates musculoskeletal health with systemic conditions, suggesting a holistic approach to patient care. Boris Schouten has not received any explicitly mentioned scientific awards. His academic advising and grant activities are not detailed in the provided text. He is involved in major research initiatives including the Krimpen Study and the FOCUM cohort , which examine long-term health outcomes in aging, with a focus on osteoarthritis and menopausal transitions.

Cecilia OlssonView profile

Professor

• Oncology Nursing
• Palliative Care
• Symptom Management
• +4 more

Cecilia Olsson is a Professor of Nursing Research at Karlstad University, specializing in oncology nursing, palliative care, and symptom management. She leads research programs focused on sexuality in cancer care, symptom clusters, and peer learning in nursing education. Her work integrates clinical practice with educational innovation, emphasizing patient-centered approaches. Principal investigator in the HeMa6 project studying sexuality impacts post-cancer treatment. Developed the SexWebEdNurse web-based intervention for cancer nurses. Steering committee member for the QCNEoL international palliative care network. Research interests include: Cancer symptom clusters and management. Palliative care quality during crises like the pandemic. Nurse competence in contact roles for cancer patients. Peer learning models for nursing students and new nurses. Key articles focus on validating communication training for nurses, family caregiver support, and telehealth interventions for post-COVID-19 patients. Collaborates with SweGCG on gynecological cancer care evaluations. Advises multiple PhD students and chairs Karlstad University's Research Ethics Committee. Actively involved in national/international nursing organizations like EONS and Swedish Cancer Nurses Society.

Donna AnkerstView profile

Associate Professor

• Biostatistics
• Clinical Risk Prediction
• Prostate Cancer Research
• +3 more

Professor Donna Ankerst holds an Associate Professorship in Biostatistics at the Technical University of Munich (TUM), affiliated with the School of Computation, Information and Technology and the Department of Mathematics. She also serves as a Research Professor at the University of Texas Health Sciences Center in San Antonio. Her work spans clinical risk prediction (e.g., prostate cancer risk calculators), deep learning for medical imaging (e.g., 3D mammograms), and climate change impacts on Bavarian forests and health. She has pioneered internationally validated tools like the prostate cancer risk calculator and collaborates with TUM's Rechts der Isar Hospital and School of Life Sciences. Education: PhD in Statistics (Carnegie Mellon University), postdoctoral training at Harvard University and the Fred Hutchinson Cancer Research Center. Awards include the 2018 TUM PhD Supervisor Award and the 2015 Prostate Cancer Dream Challenge win. She teaches courses on applied regression, statistical computing, and data analysis. Research focuses on integrating biostatistical methods with clinical and environmental data, including multi-center trials, electronic health records, and climate modeling. Key projects include predictive algorithms for cancer diagnosis and climate-driven health outcomes. Grants managed include collaborations on kidney/pancreas transplantation outcome tools and prostate cancer decision support systems. Labs/Teams: Part of TUM's Data Science initiatives and interdisciplinary groups like the TUM School of Life Sciences. She chairs the Data Safety Board for the WISDOM breast cancer trial and edits Biometrics reviews.

• Infectious Diseases
• Immunology
• Microbiology
• +3 more

Alison Carey is a researcher at Queensland University of Technology, specializing in infectious diseases, immunology, and microbiology. Her work focuses on understanding the pathogenesis of bacterial infections such as Chlamydia and Group B Streptococcus, with a particular emphasis on genital and urinary tract infections. She has contributed extensively to studies on vaccine development, immune responses, and the impact of infections on reproductive health and fertility. Her research integrates molecular biology, animal models, and clinical insights to address unresolved questions in microbial pathogenesis and treatment strategies. Dr. Carey's PhD (2010) explored novel vaccine strategies against genital chlamydial infections. Her recent work includes investigations into the role of cytokines like IL-17A and IL-10 in infection outcomes, the immune mechanisms driving chlamydial persistence, and the development of prophylactic/therapeutic interventions. She collaborates widely on projects involving vaccine design, antibiotic efficacy, and the interplay between bacterial infections and host immune responses. Key areas of focus include: 1) Mechanisms of Chlamydia-induced infertility and its long-term consequences; 2) Immune pathways governing bacterial colonization and clearance in the female reproductive tract; 3) Development of dual-purpose contraceptives with antimicrobial activity. Her work has significant implications for public health strategies and clinical management of sexually transmitted infections.

Nancy MumaView profile

Professor

• Neuropharmacology
• Serotonin Receptor Signaling
• Huntington's Disease
• +3 more

Nancy Muma is a Professor and Chair of the Department of Pharmacology & Toxicology at the University of Kansas School of Pharmacy. Her research focuses on neuropharmacology, with a particular emphasis on understanding serotonin receptor signaling pathways and their roles in neuropsychiatric disorders such as depression and schizophrenia, as well as neurodegenerative diseases like Huntington's disease. She has held academic positions at Loyola University Chicago and Johns Hopkins University, and her work integrates drug discovery, molecular biology, and translational research. Education: Postdoctoral Fellowship at Johns Hopkins University School of Medicine (1989); Ph.D. in Pharmacology from the University of Louisville (1985). Research Interests: Serotonin pharmacology, novel post-translational modifications of receptors (e.g., SUMOylation), estrogen receptor GPER1's role in mood disorders, and drug development for neurodegeneration. Her team has identified biological probes targeting mutant huntingtin protein interactions in Huntington's disease, advancing potential therapeutic strategies. Publications: Over 90 peer-reviewed articles, including recent work on mitochondrial dysfunction in Alzheimer's and small-molecule inhibitors of huntingtin-calmodulin interactions. Research trends emphasize cross-disciplinary approaches to neuropharmacology and protein signaling. Grants & Collaborations: Funded by NIH and other agencies for projects on serotonin receptors, neurodegeneration, and drug development. Collaborates with medicinal chemists and neurobiologists to translate basic research into clinical applications. Labs/Teams: Leads the Pharmacology & Toxicology lab at KU, focusing on neuropharmacological mechanisms and drug discovery. Active in mentoring graduate students and postdoctoral researchers in pharmacology and toxicology.